Top Markets
Coin of the day
Hubei Biocause Pharmaceutical Co., Ltd. Hubei Biocause Pharmaceutical Co., Ltd.

Hubei Biocause Pharmaceutical Co., Ltd.

000627
Rang in aandelen #9082
Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a... Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a multifaceted business. Its primary activities within China involve the provision of life and motor insurance policies. Additionally, the company is engaged in the pharmaceutical, chemical, and new energy fuel industries. Specifically, in the pharmaceutical field, it conducts contract research, development, and manufacturing of active pharmaceutical ingredients (APIs), intermediate compounds, and various drug forms such as tablets, granules, and capsules. Its chemical offerings include substances like dimethyl ether gas and a-chloropropionyl chloride. The firm also boasts an international presence, distributing its products to markets including the United States, the European Union, and other global locations.
Aandeelprijs
$0.2219522
Laatst gesynchroniseerd: 2025-09-11
Marktkapitalisatie
$1.10B
Verandering (1 dag)
0.04%
Verandering (1 jaar)
0.17%
Land
CN
Handel Hubei Biocause Pharmaceutical Co., Ltd. (000627)
P/B-ratio voor Hubei Biocause Pharmaceutical Co., Ltd. (000627)
P/B-ratio op August 2026 TTM: 0.38
Volgens de meest recente financiële rapporten en aandelenkoers van Hubei Biocause Pharmaceutical Co., Ltd. is de huidige P/B-ratio (TTM) 0.38. Eind 2022 had het bedrijf een P/B-ratio van 0.73.
P/B-ratiohistoriek voor Hubei Biocause Pharmaceutical Co., Ltd. van 2000 tot 2026
P/B-ratio aan het einde van elk jaar
Jaar P/B-ratio Wijzigen
2026 (TTM) 0.38 -43.43%
2023 0.68 -6.16%
2022 0.73 0.55%
2021 0.73 -36.31%
2020 1.14 -30.43%
2019 1.64 12.76%
2018 1.45 -21.73%
2017 1.85 -17.26%
2016 2.24 -73.63%
2015 8.50 95.40%
2014 4.35 71.99%
2013 2.53 2.54%
2012 2.47 -12.18%
2011 2.81 -35.80%
2010 4.37 31.02%
2009 3.34 138.44%
2008 1.40 -82.25%
2007 7.89 243.90%
2006 2.29 173.77%
2005 0.84 -59.16%
2004 2.05 -13.52%
2003 2.37 -64.68%
2002 6.71 59.91%
2001 4.20 -11.67%
2000 4.75 0.00%
P/B-ratio voor vergelijkbare bedrijven of concurrenten